Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation



Psychoemotional disturbances are an important component of the functional gastrointestinal disorders. It was suggested that Latent Dysphoria along with anxiety and depression are important features of negative emotions in patients with functional constipation (FC) and it has a major impact on social functioning. 60 women with FC according to the IV Rome criteria, aged from 18 to 62 (34.72±11.43 years) and duration of the disease ― 12.84±11.34 years were included into the study. The assessment of emotional disorders and quality of life was performed by State-Trait Anxiety Inventory, Hamilton Depression Scale, the four-dimensional questionnaire (4DSQ), SF-36 Questionnaire, new Latent Dysphoria Checklist. The assessment of the severity of somatic symptoms was carried out using methods accepted in the practice of gastroenterologists. Results: 73% of patients showed increased anxiety, 50% ― signs of depression. Latent dysphoria by Latent Dysphoria Checklist was found in 48% of patients. The patients were divided into two subgroups according to the presence / absence of the latent dysphoria. There was no difference in severity of somatic symptoms between subgroups. As for emotional disturbances the difference was found. Indicators of emotional disturbances (anxiety, distress, depression, somatization) were significantly higher in the subgroup of patients with latent dysphoria (p<0.05) and the quality of life indicators ― significantly lower (p<0.05). Thus, our findings support the hypothesis that emotional disturbances in women with FC include latent dysphoria together with anxiety and depression. This complex but not severity of somatic symptoms negatively affects social functioning. The main limitations of the study are as follows: the small sample size, the absence of a comparison group, and the inapplicability of the findings for the male population. The study of the prevalence and specificity of latent dysphoria in other pathological conditions will be the subjects of the further research.

General Information

Keywords: emotional disturbances, latent dysphoria, anxiety, depression, functional constipation, psychometrics, quality of life

Journal rubric: Empirical Research

Article type: scientific article


Received: 16.03.2021


For citation: Morozova M.A., Rupchev G.E., Alekseev A.A., Ulyanin A.I., Poluektova E.A., Ivashkin V.T. Latent Dysphoria in the Structure of Emotional Disorders in Patients with Functional Constipation [Elektronnyi resurs]. Klinicheskaia i spetsial'naia psikhologiia = Clinical Psychology and Special Education, 2021. Vol. 10, no. 4, pp. 68–92. DOI: 10.17759/cpse.2021100404. (In Russ., аbstr. in Engl.)


  1. Amirdzhanova V.N., Goryachev D.V., Korshunov N.I. et al. Populyatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezul'taty mnogotsentrovogo issledovaniya kachestva zhizni «MIRAZh») [SF-36 questionnaire population quality of life indices Objective]. Nauchno-prakticheskaya revmatologiya=Rheumatology Science and Practice, 2008, vol. 46, no. 1, pp. 36-48. DOI: 10.14412/1995-4484-2008-852 (In Russ., abstr. in Engl.).
  2. Lyuban-Plotstsa B., Pel'dinger V., Kreger F. Psikhosomaticheskii bol'noi na prieme
    u vracha: Per. s nem. [Psychosomatic patient at the doctor's appointment]. Saint-Petersburg: Sankt-Peterburggskii psikhonevrologicheskii institut imeni V.M. Bekhtereva, 1994. 245 p. (In Russ.).
  3. Mnatsakanyan M.G., Pogromov A.P., Tashchyan O.V. et al. «Indeks vistseral'noi chuvstvitel'nosti» u bol'nykh SRK raznogo vozrasta [“Visceral sensitivity index” in patients with IBS of different ages]. Eksperimental'naya i klinicheskaya gastroenterologiya =Experimental and Clinical Gastroenterology, 2020, vol. 174, no. 2, pp. 65–70. DOI: 10.31146/1682-8658-ecg-174-2-65-70 (In Russ., abstr. in Engl.).
  4. Morozova M.A., Alekseev A.A., Rupchev G.E. Latentnaya disforiya: instrument dlya skriningovoi diagnostiki (predvaritel'nye dannye) [Latent dysphoria: an instrument of screening and diagnosis (preliminary results)]. Zhurnal nevrologii i psikhiatrii im. SS Korsakova=S.S. Korsakov Journal of Neurology and Psychiatry, 2018, vol. 118, no. 3,
    pp. 77–82. DOI: 10.17116/jnevro20181183177-82 (In Russ., abstr. in Engl.).
  5. Morozova M.A., Rupchev G.E., Alekseev A.A. et al. Disforicheskii spektr emotsional'nykh rasstroistv u bol'nykh s sindromom razdrazhennogo kishechnika [Dysphoric spectrum of emotional disorders at irritable bowel syndrome]. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii=Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2017, vol. 27, no. 1, pp. 12–22. DOI: 10.22416/1382-4376-2017-27-1-12-22 (In Russ., abstr. in Engl.).
  6. Soldatkina V.A. Klinicheskaya psikhometrika: uchebnoe posobie [Clinical psychometrics: a textbook]. Rostov-on-Don: RostGMU, 2018. 339 p.
  7. Tiganov A.S. Klinicheskaya psikhopatologiya [Clinical psychopathology]. In
    A.S. Tiganova (ed.), Rukovodstvo po psikhiatrii=Manual of Psychiatry. Vol. 1. Moscow: Meditsina, 1999, pp. 27–78. (In Russ.).
  8. Khanin Yu.L. Kratkoe rukovodstvo k primeneniyu shkaly reaktivnoi lichnostnoi trevozhnosti Ch. D. Spilbergera [A brief guide to the use of the C.D. Spielberger state-trait anxiety inventory]. Leningrad: LNIIFK, 1976. 40 p. (In Russ.).
  9. Björkman I., Simrén M., Ringström G. et al. Patients’ experiences of healthcare encounters in severe irritable bowel syndrome: an analysis based on narrative and feminist theory. Journal of Clinical Nursing, 2016, vol. 25, no. 19-20, pp. 2967–2978. DOI: 10.1111/ jocn.13400
  10. Çakmak B.B., Özkula G., Işıklı S. et al. Anxiety, depression, and anger in functional gastrointestinal disorders: a cross-sectional observational study. Psychiatry Research, 2018, vol. 268, pp. 368–372. DOI: 10.1016/j.psychres.2018.06.046
  11. Dayer A., Aubry J.M., Roth L. et al. A theoretical reappraisal of mixed states: dysphoria as a third dimension. Bipolar Disorders, 2000, vol. 2, no. 4, pp. 316–324. DOI: 10.1034/j.1399-5618.2000.020404.x
  12. Drossman D.A. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? The American Journal of Medicine, 1999, vol. 107, no. 5,
    pp. 41–50. DOI: 10.1034/j.1399-5618.2000.020404.x
  13. Dumitraşcu D.L., Acalovschi M., Pascu O. Hostility in patients with chronic constipation. Romanian Journal of Internal Medicine, 1998, vol. 36, no. 3-4, pp. 239–243.
  14. Grinsvall C., Törnblom H., Tack J. et al. Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome. United European Gastroenterology Journal, 2018, vol. 6, no. 2, pp. 300–309. DOI: 10.1177/ 2050640617715851
  15. Gudleski G.D., Satchidanand N., Dunlap L.J. et al. Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States. Behaviour Research and Therapy, 2017, vol. 88, pp. 65–75. DOI: 10.1016/j.brat.2016.07.006
  16. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, And Psychiatry, 1960, vol. 23, no. 1, pp. 56–62.
  17. Hu Z., Li M., Yao L. et al. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterology, 2021, vol. 21, no. 1, pp. 1–18. DOI: 10.1186/s12876-020-01593-5
  18. Jerndal P., Ringström G., Agerforz P. et al. Gastrointestinal‐specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterology & Motility, 2010, vol. 22, no. 6, pp. 646–e179. DOI: 10.1111/j.1365-2982.2010.01493.x
  19. Kellner R., Hernandez J., Pathak D. Self-rated inhibited anger, somatization and depression. Psychotherapy and Psychosomatics, 1992, vol. 57, no. 3, pp. 102–107. DOI: 10.1159/000288582
  20. Lewis S. J., Heaton K. W. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology, 1997, vol. 32, no. 9, pp. 920–924. DOI: 10.4103/0019-5545.148526
  21. Midenfjord I., Polster A., Sjövall H. et al. Anxiety and depression in irritable bowel syndrome: exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility, 2019, vol. 31, no. 8, p. e13619. DOI: 10.1111/nmo.13619
  22. Midenfjord I., Borg A., Törnblom H. et al. Cumulative effect of psychological alterations on gastrointestinal symptom severity in irritable bowel syndrome. Official Journal of the American College of Gastroenterology ACG, 2021, vol. 116, no. 4, pp. 769–779. DOI: 10.14309/ajg.0000000000001038
  23. Mikocka‐Walus A., Turnbull D., Moulding N. et al. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. Journal of Gastroenterology and Hepatology, 2008, vol. 23, no. 7pt1, pp. 1137–1143. DOI: 10.1111/j.1440-1746.2007.05245.x
  24. Shiha M.G., Asghar Z., Thoufeeq M. et al. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterology & Motility, 2021, no. 14, p. e14121. DOI: 10.1111/nmo.14121
  25. Sperber A.D., Bangdiwala S.I., Drossman D.A. et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology, 2021, vol. 160, no. 1, pp. 99–114.
  26. Spielberger C.D., Gorsuch R.L., Lushene L.E. et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983. 36 p.
  27. Stanculete M.F., Capatina O., Pojoga C. et al. Anger Mediates the Relationship between Pain and Depression in Irritable Bowel Syndrome. Journal of Gastrointestinal & Liver Diseases, 2019, vol. 28, no. 4, pp. 415–419. DOI: 10.15403/jgld-533
  28. Starcevic V. Dysphoric about dysphoria: towards a greater conceptual clarity
    of the term. Australasian Psychiatry, 2007, vol. 15, no. 1, pp. 9–13. DOI: 10.1080/ 10398560601083035
  29. Staudacher H.M., Mikocka-Walus A., Ford A.C. et al. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. The Lancet Gastroenterology & Hepatology, 2021, vol. 6, no. 5, pp. 401–410. DOI: 10.1016/S2468-1253(20)30363-0
  30. Terluin B., van Marvijk H.W.J., Adèr H.J. et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC psychiatry, 2006, vol. 6, p. 34. DOI: 10.1186/1471-244X-6-34
  31. Umrani S., Jamshed W., Rizwan A. et al. Association between psychological disorders and Irritable Bowel Syndrome. Cureus, 2021, vol. 13, no. 4, p. e14513. DOI: 10.7759/ cureus.14513
  32. Van Oudenhove L., Törnblom H., Störsrud S. et al. Depression and somatization are associated with increased postprandial symptoms in patients with irritable bowel syndrome. Gastroenterology, 2016, vol. 150, no. 4, pp. 866–874. DOI: 10.1053/ j.gastro.2015.11.010
  33. Ware J.E., Snow K.K., Kosinski M. et al. SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993. 316 p.

Information About the Authors

Margarita A. Morozova, Doctor of Medicine, Professor of the Department for Psychiatry Professional Training (Department of Residency and Postgraduate studies), Head of Laboratory of Psychopharmacology, Mental Health Research Center, Moscow, Russia, ORCID:, e-mail:

Georgiy E. Rupchev, PhD in Psychology, research fellow of the Laboratory of psychopharmacology, Mental Health Research Center, Moscow, Russia, ORCID:, e-mail:

Andrey A. Alekseev, Clinical psychologist, Laboratory of psychopharmacology, Mental Health Research Center, Moscow, Russia, ORCID:, e-mail:

Anatoly I. Ulyanin, Gastroenterologist, Department of Chronic Diseases of the Intestines and Pancreas, .M. Sechenov First Moscow State Medical University, Moscow, Russia, ORCID:, e-mail:

Elena A. Poluektova, Doctor of Medicine, Professor of Department of Propedeutics of Internal Diseases, Faculty of Medicine, V.H. Vasilenko Clinic of the Propaedeutics of Internal Diseases, Gastroenterology and Hepatology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia, ORCID:, e-mail:

Vladimir T. Ivashkin, Doctor of Medicine, Academician of the Russian Academy of Sciences, Professor, Head of Department of Propedeutics of Internal Diseases, Faculty of Medicine, Sechenov First Moscow State Medical University, Moscow, Russia, ORCID:, e-mail:



Total: 767
Previous month: 14
Current month: 18


Total: 359
Previous month: 13
Current month: 13